The field of immunology has long recognized the pivotal role of T lymphocytes in the adaptive immune system, particularly in pathogen defense, tumor ...
Some of those patients will experience refractory cancer – cancer that does not respond to initial treatment or becomes ...
LONDON - Autolus Therapeutics plc (NASDAQ:AUTL), a biopharmaceutical company specializing in T cell therapies for cancer, has announced its participation in the upcoming 2025 Tandem Meetings | ...
Caribou Biosciences has launched a Phase 1 trial testing its CAR T-cell therapy CB-010 for lupus affecting the kidneys and ...
We've assembled 50 products that live in that delightful sweet spot between "absolutely ridiculous" and "why didn't I think ...